Literature DB >> 31089806

Statement of the DOG, the RG, and the BVA on the therapeutic use of voretigene neparvovec (Luxturna™) in ophthalmology. English version : January 2019.

.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31089806     DOI： 10.1007/s00347-019-0906-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  30 in total

1.  Early-onset severe rod-cone dystrophy in young children with RPE65 mutations.

Authors:  B Lorenz; P Gyürüs; M Preising; D Bremser; S Gu; M Andrassi; C Gerth; A Gal
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Shared decision-making, control preferences and psychological well-being in patients with RPE65 deficiency awaiting experimental gene therapy.

Authors:  Monika Nelles; Knut Stieger; Markus N Preising; Johannes Kruse; Birgit Lorenz
Journal:  Ophthalmic Res       Date:  2015-08-08       Impact factor: 2.892

3.  Improvement and decline in vision with gene therapy in childhood blindness.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Alejandro J Roman; Alexander Sumaroka; Sharon B Schwartz; Elise Heon; William W Hauswirth
Journal:  N Engl J Med       Date:  2015-05-03       Impact factor: 91.245

4.  A comprehensive clinical and biochemical functional study of a novel RPE65 hypomorphic mutation.

Authors:  Birgit Lorenz; Eugenia Poliakov; Maria Schambeck; Christoph Friedburg; Markus N Preising; T Michael Redmond
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07-03       Impact factor: 4.799

5.  Chromatic pupillometry dissects function of the three different light-sensitive retinal cell populations in RPE65 deficiency.

Authors:  Birgit Lorenz; Elisabeth Strohmayr; Steffen Zahn; Christoph Friedburg; Martin Kramer; Markus Preising; Knut Stieger
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-17       Impact factor: 4.799

6.  Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.

Authors:  Alejandro J Roman; Sharon B Schwartz; Tomas S Aleman; Artur V Cideciyan; John D Chico; Elizabeth A M Windsor; Leigh M Gardner; Gui-Shuang Ying; Elaine E Smilko; Maureen G Maguire; Samuel G Jacobson
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

7.  Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement.

Authors:  Artur V Cideciyan; Samuel G Jacobson; William A Beltran; Alexander Sumaroka; Malgorzata Swider; Simone Iwabe; Alejandro J Roman; Melani B Olivares; Sharon B Schwartz; András M Komáromy; William W Hauswirth; Gustavo D Aguirre
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  Human cone photoreceptor dependence on RPE65 isomerase.

Authors:  Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Elise Heon; Marcin Golczak; William A Beltran; Alexander Sumaroka; Sharon B Schwartz; Alejandro J Roman; Elizabeth A M Windsor; James M Wilson; Gustavo D Aguirre; Edwin M Stone; Krzysztof Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

9.  AAV2 gene therapy readministration in three adults with congenital blindness.

Authors:  Jean Bennett; Manzar Ashtari; Jennifer Wellman; Kathleen A Marshall; Laura L Cyckowski; Daniel C Chung; Sarah McCague; Eric A Pierce; Yifeng Chen; Jeannette L Bennicelli; Xiaosong Zhu; Gui-Shuang Ying; Junwei Sun; J Fraser Wright; Alberto Auricchio; Francesca Simonelli; Kenneth S Shindler; Federico Mingozzi; Katherine A High; Albert M Maguire
Journal:  Sci Transl Med       Date:  2012-02-08       Impact factor: 17.956

10.  Evaluation of an Optimized Injection System for Retinal Gene Therapy in Human Patients.

Authors:  M Dominik Fischer; Doron G Hickey; Mandeep S Singh; Robert E MacLaren
Journal:  Hum Gene Ther Methods       Date:  2016-08       Impact factor: 2.396
View more
  2 in total

1.  RPE65 c.393T>A, p.(Asn131Lys): Novel Sequence Variant Detected.

Authors:  Mirjana Bjeloš; Mladen Bušić; Ana Ćurić; Damir Bosnar; Borna Šarić; Leon Marković; Biljana Kuzmanović Elabjer; Benedict Rak
Journal:  Case Rep Ophthalmol Med       Date:  2022-04-01

2.  Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec.

Authors:  M Dominik Fischer; Katarina Stingl; Krunoslav Stingl; Melanie Kempf; Karl U Bartz-Schmidt; Spyridon Dimopoulos; Felix Reichel; Ronja Jung; Carina Kelbsch; Susanne Kohl; Friederike Charlotte Kortüm; Fadi Nasser; Tobias Peters; Barbara Wilhelm; Bernd Wissinger; Fabian Wozar; Eberhart Zrenner
Journal:  Br J Ophthalmol       Date:  2021-01-20       Impact factor: 5.908
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.